Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer

Summary

The purpose of this study is to determine whether Toremifene Citrate is effective in reducing the risk of bone fractures in men with prostate cancer who are on Androgen Deprivation Therapy.

Timeline

Start

2011-03

Primary completion

2011-09

Completion

2011-09

Outcome

Outcome not reported

Stopped: “cost of conducting the study and increased burden on the clinical trial professionals make it impossible for us to proceed with the development of the drug.”

Drugs

Indications